395 related articles for article (PubMed ID: 28034361)
1. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
2. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
3. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.
Zhang Z; Gao F; Bu H; Xiao J; Li Y
Nanomedicine; 2012 Jul; 8(5):740-7. PubMed ID: 21930110
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
[TBL] [Abstract][Full Text] [Related]
8. New supersaturating drug delivery system as strategy to improve apparent solubility of candesartan cilexetil in biorelevant medium.
Pinto JMO; Leão AF; Alves GF; Mendes C; França MT; Fernandes D; Stulzer HK
Pharm Dev Technol; 2020 Jan; 25(1):89-99. PubMed ID: 31583925
[TBL] [Abstract][Full Text] [Related]
9. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
Ugurlu T; Nalbantoglu A; Sengel-Turk CT
Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
Sezgin-Bayindir Z; Antep MN; Yuksel N
AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
Gao F; Zhang Z; Bu H; Huang Y; Gao Z; Shen J; Zhao C; Li Y
J Control Release; 2011 Jan; 149(2):168-74. PubMed ID: 20951749
[TBL] [Abstract][Full Text] [Related]
12. Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.
Gurunath S; Nanjwade BK; Patil PA
Drug Dev Ind Pharm; 2015 Jan; 41(1):170-6. PubMed ID: 24168234
[TBL] [Abstract][Full Text] [Related]
13. Mixed Pluronic/lecithin micelles formulation for oral bioavailability of candesartan cilexetil drug:
Mahajan H; Patel HS; Ray D; Aswal VK; Sharma RK; Tandel H
Drug Dev Ind Pharm; 2024 Jan; 50(1):23-35. PubMed ID: 38079333
[TBL] [Abstract][Full Text] [Related]
14. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.
Dudhipala N; Veerabrahma K
Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and
Amer AM; Allam AN; Abdallah OY
Drug Dev Ind Pharm; 2019 Jul; 45(7):1140-1148. PubMed ID: 30912678
[TBL] [Abstract][Full Text] [Related]
16. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs.
Zhang Y; Dong K; Wang F; Wang H; Wang J; Jiang Z; Diao S
Colloids Surf B Biointerfaces; 2018 Oct; 170():497-504. PubMed ID: 29960950
[TBL] [Abstract][Full Text] [Related]
17. A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
J Pharm Sci; 2019 Nov; 108(11):3599-3608. PubMed ID: 31348934
[TBL] [Abstract][Full Text] [Related]
18. Candesartan cilexetil microemulsions for transdermal delivery: formulation, in-vitro skin permeation and stability assessment.
Malakar J; Basu A; Nayak AK
Curr Drug Deliv; 2014; 11(3):313-21. PubMed ID: 24893994
[TBL] [Abstract][Full Text] [Related]
19. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
Zafar A
J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
[TBL] [Abstract][Full Text] [Related]
20. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
